American Century Companies’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.88M | Sell |
|
|||||
|
2025
Q1 | $35M | Sell |
|
|||||
|
2024
Q4 | $44.1M | Sell |
|
|||||
|
2024
Q3 | $50.9M | Sell |
|
|||||
|
2024
Q2 | $67M | Buy |
|
|||||
|
2024
Q1 | $60.6M | Buy |
|
|||||
|
2023
Q4 | $66.3M | Buy |
|
|||||
|
2023
Q3 | $46.6M | Buy |
|
|||||
|
2023
Q2 | $45.5M | Buy |
|
|||||
|
2023
Q1 | $2.85M | Buy |
|
|||||
|
2022
Q4 | $2.18M | Buy |
|
|||||
|
2022
Q3 | $1.36M | Buy |
|
|||||
|
2022
Q2 | $941K | Buy |
|
|||||
|
2022
Q1 | $872K | Buy |
|
|||||
|
2021
Q4 | $607K | Buy |
|
|||||
|
2021
Q3 | $482K | Buy |
|
|||||
|
2021
Q2 | $450K | Buy |
|
|||||
|
2021
Q1 | $307K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $219K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $854K | Sell |
|
|||||
|
2019
Q1 | $3.94M | Hold |
|
|||||
|
2018
Q4 | $3.78M | Sell |
|
|||||
|
2018
Q3 | $4.86M | Sell |
|
|||||
|
2018
Q2 | $57M | Sell |
|
|||||
|
2018
Q1 | $68.2M | Sell |
|
|||||
|
2017
Q4 | $82.1M | Buy |
|
|||||
|
2017
Q3 | $57.2M | Buy |
|
|||||
|
2017
Q2 | $33.9M | Sell |
|
|||||
|
2017
Q1 | $33.3M | Sell |
|
|||||
|
2016
Q4 | $32.5M | Sell |
|
|||||
|
2016
Q3 | $46M | Sell |
|
|||||
|
2016
Q2 | $53.6M | Sell |
|
|||||
|
2016
Q1 | $82.2M | Buy |
|
|||||
|
2015
Q4 | $91.5M | Buy |
|
|||||
|
2015
Q3 | $51.1M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $46.3M | Sell |
|
|||||
|
2014
Q3 | $46.7M | Buy |
|
|||||
|
2014
Q2 | $38.8M | Sell |
|
|||||
|
2014
Q1 | $57.4M | Buy |
|
|||||
|
2013
Q4 | $48.8M | Buy |
|